This Boca Raton company was named South Florida’s most ‘disruptive’
The Greater Miami Chamber of Commerce has named medical device company Sensus Healthcare the most “disruptive” technology startup for 2017.
Boca Raton-based Sensus Healthcare specializes in non-invasive tools aimed at treating skin conditions, such as non-melanoma skin cancers. Its best-known device is the SRT-100 Vision, a device sold to dermatologists nationwide.
The Technology Leader of the Year Awards is an annual program that recognizes individuals and organizations in the South Florida tech community whose efforts are improving overall business performance for the region’s innovation landscape.
“We are proud to be the recipient of this prestigious award for Disruptive Technology,” said Sensus Healthcare CEO Joe Sardano.
Founded in 2010, Sensus went public in the summer of 2016, with shares trading on the Nasdaq Capital Market under the ticker SRTS. The company has a market capitalization of about $59 million. Last year, the company booked revenue of more than $14 million, a 44 percent uptick compared to revenue generated in 2015.
Source: South Florida Business Journal
The Benefits of SRT
Along with eliminating the risks for post-surgical infections and complications, the SRT-100™ provides patients and physicians with a safe and effective treatment option that offers many benefits, including:
- 95%+ cure rates that rival surgery
- No anesthesia, cutting, bleeding, stitching or pain
- No downtime or lifestyle restrictions
- Super cosmesis, no unsightly scarring
- No need for post-treatment reconstructive surgeries